AXIM Biotechnologies Reports Fiscal 2017 Results, Says Making “Solid Progress”

Dr. Anastassov also noted the company received two patent allowances for cannabinoids -based ophthalmic solutions, which are used to treat glaucoma and conjunctival inflammation. It also has filed a new patent for a chewing gum that has a “controlled release of cannabinoids and opioid agonists and …

Read More

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.